Display options
Share it on

JMIR Cancer. 2016 Aug 25;2(2):e11. doi: 10.2196/cancer.5367.

Like or Dislike? Impact of Facebook on Ewing Sarcoma Treatment.

JMIR cancer

Paul Ruckenstuhl, Michael Schippinger, Paul Liebmann, Andreas Leithner, Gerwin Bernhardt

Affiliations

  1. Department of Orthopedic Surgery, Medical University Graz, Graz, Austria.
  2. Department of General Surgery, Evangelisches Krankenhaus, Vienna, Austria.

PMID: 28410188 PMCID: PMC5369625 DOI: 10.2196/cancer.5367

Abstract

BACKGROUND: An increasing number of patients are raising their voices in online forums to exchange health-related information. Facebook is the leading social media platform with more than 1 billion international daily users recorded in the summer of 2015. Facebook has a dynamic audience and is utilized in a number of ways, discussing medical issues being one of them. Ewing sarcoma mainly affects teenagers and young adults. Additionally, many individuals within this age group are regular users of Facebook. However, little is known about the impact of this modern way of communication via Web-based platforms on patients with Ewing sarcoma and their social environment.

OBJECTIVE: The aim of this study was to analyze and compare Ewing sarcoma patients' and relatives' behavior on Facebook to draw conclusions regarding the impact of Facebook on Ewing sarcoma treatment.

METHODS: We examined a Facebook group named "Ewing Sarcoma Awareness" that is used to exchange information for both patients and relatives regarding Ewing sarcoma. A self-designed questionnaire was used to compare patients' and relatives' answers. Additionally, we analyzed all processes (posts, likes, threads, links) in the group for 6 consecutive months. A total of 65 members of the Facebook group (26 patients, 39 relatives) out of 2227 international group members participated in our study.

RESULTS: More than 70% (46/65) of all participants reported that they use the group Ewing Sarcoma Awareness as a source of information about Ewing sarcoma. Of the participants, 89% (58/65) agreed on our scale from a little to a lot that being in contact with other affected people through the group makes it easier to handle the diagnosis. In this study, 20% (13/65) of all participants reported that the group affected their choice of treatment and 15% (10/65) of participants were influenced in the selection of their specialist. Regarding the recommendation of the Facebook group toward other people, significant differences (P=.003) were found comparing patients' and relatives' results. During the last 6 months most activities in the group concerned sharing destiny and handling the diagnosis.

CONCLUSIONS: The Facebook group Ewing Sarcoma Awareness has a relevant impact on group members regarding their choice of treatment. Moreover, participants turn toward the group to receive mental and emotional support in everyday life. Statements made within the group are in part questionable from a medical point of view and the impact made by these statements on patients' care requires further evaluation.

©Paul Ruckenstuhl, Michael Schippinger, Paul Liebmann, Andreas Leithner, Gerwin Bernhardt. Originally published in JMIR Cancer (http://cancer.jmir.org), 25.08.2016.

Keywords: Ewing sarcoma; Facebook; social media; social media networking

References

  1. Am J Public Health. 2010 Jul;100(7):1282-9 - PubMed
  2. J Asthma. 2011 Oct;48(8):824-30 - PubMed
  3. J Med Internet Res. 2015 Dec 31;17(12):e291 - PubMed
  4. J Med Internet Res. 2009 Nov 27;11(4):e48 - PubMed
  5. J Adolesc Health. 2011 Jul;49(1):15-20 - PubMed
  6. J Gen Intern Med. 2008 Jul;23(7):954-7 - PubMed
  7. J Clin Oncol. 2015 Sep 20;33(27):3036-46 - PubMed
  8. Wien Med Wochenschr. 2014 Sep;164(17-18):353-7 - PubMed
  9. JMIR Res Protoc. 2013 Nov 28;2(2):e52 - PubMed
  10. J Med Internet Res. 2004 Sep 29;6(3):e34 - PubMed
  11. Pediatrics. 2014 May;133(5):e1345-53 - PubMed
  12. Am Psychol. 2000 Feb;55(2):205-17 - PubMed
  13. J Med Internet Res. 2011 Feb 04;13(1):e16 - PubMed
  14. J Med Internet Res. 2014 Jan 14;16(1):e10 - PubMed
  15. Telemed J E Health. 2012 Jul-Aug;18(6):404-8 - PubMed
  16. J Community Health. 2016 Feb;41(1):174-9 - PubMed
  17. BMJ. 2009 Feb 17;338:b49 - PubMed
  18. J Med Internet Res. 2014 Aug 04;16(8):e182 - PubMed
  19. J Health Commun. 2010;15 Suppl 3:216-35 - PubMed
  20. MedGenMed. 2007 Oct 11;9(4):9 - PubMed
  21. J Med Internet Res. 2011 Nov 11;13(4):e92 - PubMed
  22. Patient Educ Couns. 2010 Mar;78(3):329-36 - PubMed
  23. J Gen Intern Med. 2011 Mar;26(3):287-92 - PubMed
  24. J Med Internet Res. 2013 Aug 28;15(8):e184 - PubMed
  25. J Health Commun. 2015;20(2):237-43 - PubMed
  26. J Am Med Inform Assoc. 2010 Jul-Aug;17(4):373-4 - PubMed
  27. West J Med. 1999 Nov-Dec;171(5-6):302-5 - PubMed
  28. Patient Educ Couns. 2006 Oct;63(1-2):24-8 - PubMed
  29. Postgrad Med J. 2009 Sep;85(1007):455-9 - PubMed
  30. Asian Pac J Cancer Prev. 2014;15(1):327-30 - PubMed
  31. J Med Internet Res. 2014 Dec 02;16(12):e267 - PubMed
  32. Inform Health Soc Care. 2009 Mar;34(2):91-9 - PubMed
  33. Dermatol Clin. 2009 Apr;27(2):133-6, vi - PubMed
  34. Hematol Oncol Clin North Am. 2013 Oct;27(5):1007-19 - PubMed
  35. BMJ. 2003 Jun 14;326(7402):1279-80 - PubMed
  36. Health Educ Res. 2001 Dec;16(6):671-92 - PubMed
  37. J Med Internet Res. 2013 Apr 23;15(4):e85 - PubMed

Publication Types